Transcarent, Inc. entered a merger agreement on January 8, 2025, to acquire Accolade, Inc. (ACCD) in an all-cash deal worth $621 million.
Under the agreement, Transcarent will acquire Accolade for $7.03 per share in cash, representing a premium of 109.85% from the stock’s last close.